Instanyl sets new standard in management of breakthrough cancer pain
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain.
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain.
They say by using the natural orifices of the body and the body’s own natural scar the belly-button (or umbilicus), it will be possible to insert robots into the body which can help perform every surgical procedure.
The Italian Pharmaceuticals Agency (AIFA) ruled late on Thursday that the drug would not be sold in pharmacies and only be administered by doctors.